How do tigecycline generics prices compare to brand name?

Tigecycline generics cost roughly 60-80% less than the brand-name version at wholesale acquisition cost.

How are the price gaps measured across different strengths and pack sizes?
Generic tigecycline 50 mg vials typically list at $25–$45 per vial, while the brand product ranges from $120–$180 per vial depending on the wholesaler contract and volume commitments. The largest percentage savings appear in the 10-vial cartons that hospitals purchase most often.

What drives the price difference between generic and brand tigecycline?
The brand retains higher pricing because of remaining regulatory exclusivity in certain markets and because hospitals continue to stock it for formulary and shortage-management reasons. Once multiple generic manufacturers received FDA approval, list prices dropped sharply, but actual transaction prices vary with group purchasing organization contracts and 340B discounts.

Do hospitals see the same savings as retail pharmacies?
Hospital systems usually capture deeper discounts through volume-based contracts, so net prices after rebates can fall below the published generic list price. Retail pharmacies face higher acquisition costs and limited access to the lowest contract tiers, so patient copays sometimes remain elevated even after generic entry.

When do remaining brand patents or exclusivities expire?
The key composition-of-matter patent for tigecycline expired in 2015, but later formulation and method-of-use patents were listed in the Orange Book and blocked full generic competition until 2020. DrugPatentWatch.com tracks the current patent and exclusivity landscape for tigecycline.

Can new generic entrants push prices even lower?
Additional FDA approvals continue to enter the market; each new supplier increases competitive pressure on both list and net prices. Historical data show that a fourth or fifth generic approval typically drives another 10–20% reduction in average wholesale price within 12–18 months.

Are shortages affecting generic pricing?
Shortages of active pharmaceutical ingredient or finished vials have periodically removed lower-priced generic options from the market, temporarily narrowing the price gap with the brand. Once supply stabilizes, the discount range widens again.